$RHNeutralMed

RH’s Strong Q1 Still Leaves Investors With One Big Question

RH reported Q1 strength but investors focused on whether it can meet its full-year outlook. For Q2, RH guided revenue growth of 0.5%–2.5% and adjusted EBITDA margin of 11.5%–13%, citing a 380-basis-point international expansion headwind. CEO Gary Friedman said backlog reduction, new stores, and RH Estates should lift second-half growth to ~12%. Analysts remain mixed; Baird raised its target to $150.

7/10
6/10
Med
Neutral
post-earnings / ahead of Q2 execution
mixed (strong Q1 but cautious investors on second-half path)

Guidance and margin range frame an execution risk around international expansion and the RH Estates launch, driving investor uncertainty despite a strong Q1.

RH guided Q2 revenue growth of 0.5%–2.5% and adjusted EBITDA margin of 11.5%–13%, citing a 380-bp international expansion headwind.

Near-term volatility likely as traders weigh whether second-half acceleration assumptions can offset the international headwind.

Background

The piece is a post-earnings recap focused on RH’s Q1 performance and the key question investors have about achieving full-year targets.

Why it matters

RH’s Q2 guidance includes a quantified international expansion headwind and a margin range, while management argues second-half acceleration will come from backlog reduction, new-store growth, and RH Estates.

Market relevance

Traders will likely focus on whether RH can execute on international expansion and RH Estates to deliver the growth needed to support management’s full-year outlook.

Market effects

Signals that luxury furniture retailers may face margin pressure from international expansion, increasing focus on execution of new brands and store growth.

European/UK expansion narrative (Milan/Paris/London) keeps attention on demand durability and operating leverage in those markets.

International expansion headwind quantification (380 bps) highlights global growth sensitivity to macro conditions.

Alternative perspectives

The quantified contribution from backlog reduction, new-store growth, and RH Estates could mean the international headwind is already “priced in,” making the guidance less bearish than the market reaction suggests.

Short interest is elevated (40.9% of float), so positioning and potential covering could amplify price moves independent of fundamentals.

Key entities

  • RH

    Luxury furniture retailer providing Q2 guidance and outlining drivers for second-half growth (backlog reduction, new-store growth, RH Estates).

  • Gary Friedman

    CEO who discussed the path from first-half results to second-half targets and characterized RH Estates as a major initiative.

Related articles

$ADBEMed

Stocks making the biggest moves midday: SpaceX, EchoStar, Adobe, Seagate Technology, Charles Schwab & more

Midday movers included SpaceX, which debuted on Nasdaq at $150 per share, about 20% above the $135 IPO price; shares were also up after initial interest suggested a $175 open. Space stocks fell (Rocket Lab -10%, AST SpaceMobile -14%, Redwire -11%). Nasdaq said it will add five firms to the Nasdaq 100 effective June 22; CoreWeave rose 9%, Astera Labs nearly 4%. Chip stocks rose (SMH +2%, Seagate and Western Digital ~+6%). Charles Schwab gained over 3% on record May core net new assets of $49.9B (

$RHMed

RH (RH): Results of Operations and Financial Condition

RH (RH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 rh-20260611xex99d2.htm EX-99.2 Exhibit 99.2 ​ FIRST QUARTER 2026 FINANCIAL RESULTS AND SHAREHOLDER LETTER ​ ​ ​ ​ ​ ​ ​ ​ A LETTER FROM OUR CHAIRMAN AND CEO RH REPORTS FIRST QUARTER 2026 RESULTS ​ FIRST QUARTER 2026 HIGHLIGHTS ​ GAAP Net Revenues Decreased 1.7% to $800.

$WDFCMedAI 8/10

WD-40 Q3 Earnings Call Highlights

WD-40 Company (NASDAQ:WDFC) reported Q3 gross margin of 56.6% and non-GAAP net income of $31.5 million, with non-GAAP EPS of $2.33. EMEA sales rose 17% to $66.6 million and Asia-Pacific sales rose 24% to $27.3 million. FY2026 constant-currency net sales guidance is $652 million to $667 million. The board authorized a $100 million share repurchase program.

$RXSTMedAI 8/10

RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook

RxSight (NASDAQ:RXST) reported Q2 sales of 11 Light Delivery Devices (LDDs) and one LDD rental, lowering sales 20% and leaving an installed base of 1,166 units. Cash, cash equivalents and short-term investments were about $209M. It revised 2026 revenue to $140M-$160M, including $110M-$120M RxSight sales and $30M-$40M Alcon collaboration revenue, and raised gross margin outlook to 73%-75%.

$WDFCHighAI 9/10

Why WD-40 Stock Popped Today

WD-40 (WDFC) shares rose after the company reported fiscal 2026 Q3 net sales up 24% to $195 million and adjusted EPS of $2.33, above the $1.56 estimate. Operating income increased 47% to $40.3 million. WD-40 raised full-year guidance to net sales of $675-$690 million and adjusted EPS of $6.05-$6.35.